Quality Metrics for Breast Cancer
UC San Diego Health's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited healthcare settings to measure cancer care quality.
The data presented below are included in the CoC's quality-of-care measures for breast cancer and are for the diagnosis year 2017, the most recent year for which data is available. (Data is provided by the National Cancer Database.)
The purpose of the data is to compare the care of breast cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all measures listed below. For more information about quality and safety measures, see Quality Care.
Commission on Cancer's Quality of Care Measures
| Quality of Care for Breast Cancer Measure |
UC San Diego Health | State of California | Pacific Region | Teaching Hospitals | All Commission on Cancer-Approved Programs |
|---|---|---|---|---|---|
| Combination chemotherapy considered within four months of diagnosis (when appropriate) |
94.2% | 89.8% | 91.1% | 92.8% | 93.5% |
| Administration of hormone therapy considered within one year of diagnosis (when appropriate) |
93.0% | 88.4% | 90.2% | 91.7% | 92.0% |
| Radiation therapy administered within one year of diagnosis for women receiving breast conservation surgery (when appropriate) |
95.7% | 88.0% | 89.5% | 90.4% | 91.1% |
Hospitals Are Not All Alike
Become an Informed Consumer
At UC San Diego Health, we are dedicated to delivering the highest quality, safest care for every patient, every time. We encourage you to become an informed consumer.
Testing for Hereditary Breast Cancer
Learn About Your Risk
Up to 10 percent of all breast cancers are caused by genetic changes or mutations that can be inherited. Mutations of the BRCA1 and BRCA2 genes are understood to be responsible for most cases of inherited breast cancer. We offer genetic testing to identify BRCA and other mutations. Testing can be completed with a simple blood or oral swab test.
Study: Breast Cancer Drug Shows Potential for Rare Appendix Cancer
Researchers at University of California San Diego School of Medicine found an FDA-approved drug used...
UC San Diego Health No. 1 in San Diego, Top 20 in the Nation
UC San Diego Health has once again secured the No. 1 ranking in San Diego, according to the 2024-202...
UC San Diego Health Offers Novel Gene Therapy for Bladder Cancer
UC San Diego Health is the first health system in San Diego County to offer a new bladder-saving gen...